U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism announces the availability of funding for implementation of the Investigational New Drug-Enabling and Early-Stage Development of Medications to Treat Alcohol Use Disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional) Grant. The purpose of this grant is to develop therapeutic agents for the treatment of alcohol use disorder (AUD) and/or alcohol associated organ damage (AAOD). Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact for . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!